Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.

Journal of virological methods - 1 Aug 2010

Ciotti Marco, Marcuccilli Fabbio, Guenci Tania, Babakir-Mina Muhammed, Chiodo Federico, Favarato Mose', Perno Carlo Federico

Abstract excerpt

Genotype determination is recommended before starting anti-HCV therapy to determine the duration of treatment (PEG-Interferon+ribavirin). The Versant HCV Genotype 2.0 assay, based on the reverse hybridization of the 5'UTR segment and core region of hepatitis C virus (HCV), has been one of the assays used most widely for HCV genotyping. A multicenter evaluation of the more automated Abbott RealTime HCV Genotype II...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5' Untranslated Regions
Share to Automation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Molecular Diagnostic Techniques

Share to Reagent Kits, Diagnostic

Share to Viral Core Proteins

Share to Virology

Source

Identifiers

PMID: 20362009
DOI: 10.1016/j.jviromet.2010.03.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.PMID 20362009Read ↗

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus GenotypingSemantic proximity Read ↗

Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.Semantic proximity Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.Semantic proximity Read ↗

[Hepatitis C virus genotyping: comparison of the Abbott RealTime HCV Genotype II assay and NS5B sequencing].Semantic proximity Read ↗

Utility of the Abbott RealTime HCV Genotype Plus RUO assay used in combination with the Abbott RealTime HCV Genotype II assay.Semantic proximity Read ↗

Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype.Semantic proximity Read ↗

The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis.Semantic proximity Read ↗

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.Semantic proximity Read ↗

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.Semantic proximity Read ↗

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.Semantic proximity Read ↗

Performance of the Abbott RealTime HCV Genotype II RUO assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.